1. Home
  2. NSPR vs YSXT Comparison

NSPR vs YSXT Comparison

Compare NSPR & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo YSX Tech. Co. Ltd Class A Ordinary Shares

YSXT

YSX Tech. Co. Ltd Class A Ordinary Shares

N/A

Current Price

$1.38

Market Cap

41.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
YSXT
Founded
2005
2011
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
41.4M
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
NSPR
YSXT
Price
$0.46
$1.38
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 108.5K
8.9K
Earning Date
11-03-2026
07-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
★ N/A
$5.57
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$0.50
52 Week High
$2.41
$3.14

Technical Indicators

Market Signals
Indicator
NSPR
YSXT
Relative Strength Index (RSI) 24.56 55.56
Support Level N/A $0.94
Resistance Level $1.00 $1.47
Average True Range (ATR) 0.08 0.06
MACD -0.01 0.00
Stochastic Oscillator 2.19 40.48

Price Performance

Historical Comparison
NSPR
YSXT

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.

Share on Social Networks: